SCNI vs UDR · P/E 0.2, rev $1.3M vs P/E 26, rev $1.71B
Scinai Immunotherapeutics Ltd (SCNI) versus UDR Inc (UDR) — a side-by-side from cached financials, not a winner call.
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
UDR Inc (UDR) is a reit - residential company listed on NYSE.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
Latest reported UDR revenue for 2025-12-31 was $1.71B. Net income was $377.7M. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
SCNI currently screens at market cap $1.8M and trailing P/E 0.2. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
Not investment advice. Open the SCNI and UDR stock pages for the full models.
Not investment advice.